 |
Prospector
Profile
07.1277
|
| |
| Hydron Technologies, Inc. |
NAICS |
325620 |
| 4400-34th Street North, Suite F
St Petersburg, FL 33714 |
Description |
Cosmetics Mfg. |
| (727) 342-5050 |
Employees |
18 |
| http://www.hydron.com/ |
Revenue |
(mil) |
1.4740 |
| |
Income |
(mil) |
-0.5520 |
| |
Assets |
(mil) |
0.8970 |
| |
Liability |
(mil) |
1.2570 |
| |
(for the year ended 2005-12-31) |
| |
|
Category:
Audit Concerns
|
| |
|
Event:
Sherb & Company LLP raised substantial doubt about the ability of Hydron Technologies, Inc. to continue as a going concern after auditing its financial statements. The auditor notes that the Company has a working capital deficiency of $462,00 at December 31, 2005 and has experienced net losses of $218,668 and $137,815 in 2005 and 2004, respectively.
|
| |
|
Intellectual Property:
In January 2006, the Company was granted U.S. Patent Number 6,984,391 for its Compositions and Method for Delivery of Skin Cosmeceuticals. The Company was also granted a U.S. patent on its super-oxygenation
technology in November 2003. The Company has applied for international patents on this technology in approximately 29 countries, which are in various stages of review as of December 31, 2006. The Company was granted U.S. Patent No. 4,883,659, dated November 28, 1989, and U.S. Patent No. 5,039,516, dated August 13, 1991, which cover a stable moisturizing emulsion containing an unusual emulsifying agent, as well as the
Hydron polymer and a unique combination of ingredients. During 1999, the Company was granted U.S. Patent No. 5,879,684 for its "Line Smoothing Complex" formula, which has been clinically shown to reduce fine lines
and wrinkles. In addition, the Company has registered several trademarks relating to its cosmetic products. The Company has also received patent protection for its emulsification
process in several countries to facilitate distribution and sale of these products outside of the United States. [SEC Filing 10-KSB 04-02-07]
|
| |
|
Description:
The Company engages in the manufacture and sale of consumer and professional products, primarily in the personal care/cosmetics field.
|
| |
|
Officers:
Richard Banakus (Chair); David Pollock (CEO & Dir.); Douglas Reitz, D.C. (EVP); Karen Gray (Dir.); Ronald J. Saul (Dir.)
|
| |
|
Auditor:
Sherb & Company LLP
|
| |
|
Securities:
Common Stock-Symbol HTEC.OB; OTC BB;
17,074,961 common shares outstanding as of August 1, 2007.
|
| |
| |
| |
| return to main page |
|
|
